LOTRONEX (Sebela Pharmaceuticals Inc.)
Welcome to the PulseAid listing for the LOTRONEX drug offered from Sebela Pharmaceuticals Inc.. This Serotonin 3 Receptor Antagonists [MoA],Serotonin-3 Receptor Antagonist [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Sebela Pharmaceuticals Inc. |
NON-PROPRIETARY NAME: | alosetron hydrochloride |
SUBSTANCE NAME: | ALOSETRON HYDROCHLORIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Serotonin 3 Receptor Antagonists [MoA],Serotonin-3 Receptor Antagonist [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2016-07-11 |
END MARKETING DATE: | 0000-00-00 |
LOTRONEX HUMAN PRESCRIPTION DRUG Details:
Item Description | LOTRONEX from Sebela Pharmaceuticals Inc. |
LABELER NAME: | Sebela Pharmaceuticals Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 0.5(mg/1) |
START MARKETING DATE: | 2016-07-11 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 54766-894_35cbb9d5-639a-207a-e054-00144ff88e88 |
PRODUCT NDC: | 54766-894 |
APPLICATION NUMBER: | NDA021107 |
Other ALOSETRON HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers: